![David R. Seaton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
David R.
Seaton served as the Acting CEO, Chief Financial Officer & Secretary at MEI Pharma, Inc. from 2009 to 2010.
Prior to that, he was the Chief Financial Officer at Kazia Therapeutics Ltd. from 1999 to 2010.
He also served as the Chief Financial Officer & Secretary at Glycotex, Inc. Mr. Seaton received his undergraduate and graduate degrees from The University of New South Wales.
Eerdere bekende functies van David R. Seaton
| Bedrijven | Functie | Einde |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Financieel Directeur/CFO | 18-06-2010 |
| LITE STRATEGY, INC. | Financieel Directeur/CFO | 21-06-2010 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Researches and develops drugs | Financieel Directeur/CFO | - |
Opleiding van David R. Seaton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Researches and develops drugs | Health Technology |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
